Xeris Pharmaceuticals | XERS - Net Income


Xeris Pharmaceuticals reported $11.08M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Nektar Therapeutics USD -36.08M 978K Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organigram Holdings CAD 19.97M 57.93M Dec/2025
Ovoca Bio EUR -765K 4.89M Jun/2025
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Pharma Mar EUR 59.66M 63.76M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Sartorius EUR 56.2M 37M Mar/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Tilray USD -44.93M 44.61M Sep/2025
Zealand Pharma A/S -379.12M 25.12M Dec/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025